日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML

BRG1/BRM抑制剂联合BET抑制剂或地西他滨治疗高危MECOM重排急性髓系白血病疗效显著。

Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Davis, John A; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Wang, Jian; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Delwel, Ruud; Bhalla, Kapil N

High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition

利用高通量蛋白质组学分析评估 Menin 抑制剂引起的分化综合征

Garcia, Miriam B; Wang, Bofei; Sheikh, Irtiza; El Hajjar, Georgina; McCall, David; Nunez, Cesar; Gibson, Amber; Lorenzi, Philip L; Issa, Ghayas C; Cuglievan, Branko; Abbas, Hussein A

Immune-related toxicity profile after haematopoietic stem cell transplantation in patients with B-ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

接受利妥昔单抗、inotuzumab 和 blinatumomab 联合免疫疗法治疗的 B 细胞急性淋巴细胞白血病 (B-ALL) 患者造血干细胞移植后的免疫相关毒性特征

Okeleji, Olayinka; McCall, David; Cuglievan, Branko; Gibson, Amber; Petropoulos, Demetrios; Tewari, Priti; Connors, Jeremy; Sheikh, Irtiza N

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Revumenib 抑制 Menin 治疗 KMT2A 重排复发或难治性急性白血病 (AUGMENT-101)

Issa, Ghayas C; Aldoss, Ibrahim; Thirman, Michael J; DiPersio, John; Arellano, Martha; Blachly, James S; Mannis, Gabriel N; Perl, Alexander; Dickens, David S; McMahon, Christine M; Traer, Elie; Zwaan, C Michel; Grove, Carolyn S; Stone, Richard; Shami, Paul J; Mantzaris, Ioannis; Greenwood, Matthew; Shukla, Neerav; Cuglievan, Branko; Kovacsovics, Tibor; Gu, Yu; Bagley, Rebecca G; Madigan, Kate; Chudnovsky, Yakov; Nguyen, Huy Van; McNeer, Nicole; Stein, Eytan M

Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations

BRG1/BRM与FLT3抑制剂联合治疗对FLT3突变型AML细胞具有优异的临床前疗效

Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Hou, Hanxi; Davis, John A; Jain, Antrix; Malovannaya, Anna; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Reville, Patrick K; Flores, Lauren B; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Bhalla, Kapil N

Multimodal spatial proteomic profiling in acute myeloid leukemia

急性髓系白血病的多模态空间蛋白质组学分析

Ly, Christopher P; Veletic, Ivo; Pacheco, Christopher D; Dasdemir, Enes; Jelloul, Fatima Z; Ferri-Borgogno, Sammy; Basi, Akshay V; Gomez, Javier A; Root, Jessica L; Reville, Patrick K; Jindal, Sonali; Basu, Sreyashi; Sharma, Padmanee; Quesada, Andres E; Bueso-Ramos, Carlos; Manshouri, Taghi; Cuglievan, Branko; Garcia, Miriam; Burks, Jared K; Abbas, Hussein A

Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy

新诊断的儿童急性髓系白血病患者停止标准治疗方案并接受替代疗法后的特征和预后

Wahba, Andrew; Catueno, Samanta; Na, Katie; Dickson, Samantha; Stevens, Alexandra; Cuglievan, Branko; Redell, Michele S

Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia

对于高危KMT2Ar急性白血病,移植后维持治疗采用新近获FDA批准的revumenib。

Okeleji, Olayinka; McCall, David; Gibson, Amber; Garcia, Miriam B; Nunez, Cesar; Roth, Michael; Connors, Jeremy; Petropoulos, Demetrios; Tewari, Priti; Cuglievan, Branko; Sheikh, Irtiza N

Risk of early death after acute leukemia diagnosis among adolescents and young adults

青少年和青年急性白血病诊断后的早期死亡风险

Berkman, Amy M; Andersen, Clark R; Puthenpura, Vidya; Short, Nicholas J; Merriman, Kelly; Swaminathan, Mahesh; Cuglievan, Branko; McCall, David; DiNardo, Courtney; Nunez, Cesar; Jain, Nitin; Kadia, Tapan; Issa, Ghayas; Gibson, Amber; Garcia, Miriam B; Livingston, J Andrew; Parsons, Susan; Hildebrandt, Michelle A T; Roth, Michael E

Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma

2004年至2020年青少年和青年霍奇金淋巴瘤患者放射治疗使用趋势

Corrigan, Kelsey L; Berkman, Amy M; Gunther, Jillian; Andersen, Clark R; Wu, Susan; Gibson, Amber; Cuglievan, Branko; Garcia, Miriam B; Manzar, Gohar; Fang, Penny; De, Brian; Ahmed, Sairah; Nunez, Cesar; Hildebrandt, Michelle A T; McCall, David C; Parsons, Susan K; Roth, Michael E